Alnylam Pharmaceuticals shares owned by Front Row Advisors
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Front Row Advisors
from 13F filings
Historical chart of Front Row Advisors investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Front Row Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Front Row Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.7k | 14 | 191.43 |
| 2023-09-30 | $2.5k | 14 | 177.07 |
| 2023-06-30 | $3.0k | 14 | 214.29 |
| 2023-03-31 | $0 | 3 | 0.33 |
| 2022-09-30 | $3.0k | 14 | 214.29 |
| 2022-06-30 | $2.0k | 14 | 142.86 |
| 2022-03-31 | $2.0k | 14 | 142.86 |
| 2021-12-31 | $2.0k | 14 | 142.86 |
| 2021-09-30 | $3.0k | 14 | 214.29 |
| 2021-06-30 | $3.0k | 14 | 214.29 |
| 2021-03-31 | $2.0k | 14 | 142.86 |
| 2020-12-31 | $2.0k | 14 | 142.86 |
| 2020-09-30 | $2.0k | 14 | 142.86 |
| 2020-06-30 | $2.0k | 14 | 142.86 |
| 2020-03-31 | $2.0k | 14 | 142.86 |
| 2019-12-31 | $2.0k | 14 | 142.86 |
| 2019-09-30 | $1.0k | 14 | 71.43 |
| 2019-06-30 | $1.0k | 14 | 71.43 |
| 2019-03-31 | $1.0k | 14 | 71.43 |